PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME

Disclosed are a preparation comprising Alzheimer's disease antigen (A68), methods of obtaining this purified antigen, and methods of using this purified antigen, for instance, for diagnosing Alzheimer's disease and for detecting human autoantibodies to the Alzheimer disease antigen. The an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DEBERNARDIS, JOHN, FRANCIS, KOHNKEN, RUSSEL, EDWIN, ZINKOWSKI, RAYMOND, P, KERKMAN, DANIEL, JOSEPH
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DEBERNARDIS, JOHN, FRANCIS
KOHNKEN, RUSSEL, EDWIN
ZINKOWSKI, RAYMOND, P
KERKMAN, DANIEL, JOSEPH
description Disclosed are a preparation comprising Alzheimer's disease antigen (A68), methods of obtaining this purified antigen, and methods of using this purified antigen, for instance, for diagnosing Alzheimer's disease and for detecting human autoantibodies to the Alzheimer disease antigen. The antigen preparation according to the invention is purified in that it is substantially free of immunoglobulin G. The invention further relates to methods of making Alzheimer disease antigens that can be used instead of or along with the A68 antigen preparation (e.g., for diagnosing AD), such as recombinant human tau, tau isolated from various species including human, and phosphorylated recombinant human tau or isolated tau, as well as A68 anti-idiotypic antibodies. L'invention concerne une préparation contenant un antigène dirigé contre la maladie d'Alzheimer (A68) et des procédés d'utilisation de cet antigène, par exemple, dans le diagnostic de la maladie d'Alzheimer et la détection des auto-anticorps réagissant à l'antigène dirigé contre la maladie d'Alzheimer. On purifie la préparation de l'invention en la libérant sensiblement d'immunoglobuline G. L'invention concerne aussi des procédés de fabrication d'antigènes, dirigés contre la maladie d'Alzheimer et pouvant être utilisés en guise de substitution ou de complément à l'antigène A68 (p.ex., pour diagnostiquer la maladie d'Alzheimer), tels que du tau humain recombinant, du tau isolé à partir de différentes espèces comprenant les humains et du tau humain recombinant isolé ainsi que des anticorps anti-idiotypitques d'A68.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0078807A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0078807A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0078807A13</originalsourceid><addsrcrecordid>eNrjZAgMCA3ydPN0dVFw9AvxdHf1U3DzD1Jw9InycPX0dQ1SD1Zw8Qx2dQx21QEqcFHwdQ3x8HcJVvB3U_B3CnH09PP0cwdLhAaDWMGOvq48DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSQ-3N_AwNzCwsDc0dCYCCUAB7kufg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME</title><source>esp@cenet</source><creator>DEBERNARDIS, JOHN, FRANCIS ; KOHNKEN, RUSSEL, EDWIN ; ZINKOWSKI, RAYMOND, P ; KERKMAN, DANIEL, JOSEPH</creator><creatorcontrib>DEBERNARDIS, JOHN, FRANCIS ; KOHNKEN, RUSSEL, EDWIN ; ZINKOWSKI, RAYMOND, P ; KERKMAN, DANIEL, JOSEPH</creatorcontrib><description>Disclosed are a preparation comprising Alzheimer's disease antigen (A68), methods of obtaining this purified antigen, and methods of using this purified antigen, for instance, for diagnosing Alzheimer's disease and for detecting human autoantibodies to the Alzheimer disease antigen. The antigen preparation according to the invention is purified in that it is substantially free of immunoglobulin G. The invention further relates to methods of making Alzheimer disease antigens that can be used instead of or along with the A68 antigen preparation (e.g., for diagnosing AD), such as recombinant human tau, tau isolated from various species including human, and phosphorylated recombinant human tau or isolated tau, as well as A68 anti-idiotypic antibodies. L'invention concerne une préparation contenant un antigène dirigé contre la maladie d'Alzheimer (A68) et des procédés d'utilisation de cet antigène, par exemple, dans le diagnostic de la maladie d'Alzheimer et la détection des auto-anticorps réagissant à l'antigène dirigé contre la maladie d'Alzheimer. On purifie la préparation de l'invention en la libérant sensiblement d'immunoglobuline G. L'invention concerne aussi des procédés de fabrication d'antigènes, dirigés contre la maladie d'Alzheimer et pouvant être utilisés en guise de substitution ou de complément à l'antigène A68 (p.ex., pour diagnostiquer la maladie d'Alzheimer), tels que du tau humain recombinant, du tau isolé à partir de différentes espèces comprenant les humains et du tau humain recombinant isolé ainsi que des anticorps anti-idiotypitques d'A68.</description><edition>7</edition><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20001228&amp;DB=EPODOC&amp;CC=WO&amp;NR=0078807A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20001228&amp;DB=EPODOC&amp;CC=WO&amp;NR=0078807A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEBERNARDIS, JOHN, FRANCIS</creatorcontrib><creatorcontrib>KOHNKEN, RUSSEL, EDWIN</creatorcontrib><creatorcontrib>ZINKOWSKI, RAYMOND, P</creatorcontrib><creatorcontrib>KERKMAN, DANIEL, JOSEPH</creatorcontrib><title>PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME</title><description>Disclosed are a preparation comprising Alzheimer's disease antigen (A68), methods of obtaining this purified antigen, and methods of using this purified antigen, for instance, for diagnosing Alzheimer's disease and for detecting human autoantibodies to the Alzheimer disease antigen. The antigen preparation according to the invention is purified in that it is substantially free of immunoglobulin G. The invention further relates to methods of making Alzheimer disease antigens that can be used instead of or along with the A68 antigen preparation (e.g., for diagnosing AD), such as recombinant human tau, tau isolated from various species including human, and phosphorylated recombinant human tau or isolated tau, as well as A68 anti-idiotypic antibodies. L'invention concerne une préparation contenant un antigène dirigé contre la maladie d'Alzheimer (A68) et des procédés d'utilisation de cet antigène, par exemple, dans le diagnostic de la maladie d'Alzheimer et la détection des auto-anticorps réagissant à l'antigène dirigé contre la maladie d'Alzheimer. On purifie la préparation de l'invention en la libérant sensiblement d'immunoglobuline G. L'invention concerne aussi des procédés de fabrication d'antigènes, dirigés contre la maladie d'Alzheimer et pouvant être utilisés en guise de substitution ou de complément à l'antigène A68 (p.ex., pour diagnostiquer la maladie d'Alzheimer), tels que du tau humain recombinant, du tau isolé à partir de différentes espèces comprenant les humains et du tau humain recombinant isolé ainsi que des anticorps anti-idiotypitques d'A68.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgMCA3ydPN0dVFw9AvxdHf1U3DzD1Jw9InycPX0dQ1SD1Zw8Qx2dQx21QEqcFHwdQ3x8HcJVvB3U_B3CnH09PP0cwdLhAaDWMGOvq48DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSQ-3N_AwNzCwsDc0dCYCCUAB7kufg</recordid><startdate>20001228</startdate><enddate>20001228</enddate><creator>DEBERNARDIS, JOHN, FRANCIS</creator><creator>KOHNKEN, RUSSEL, EDWIN</creator><creator>ZINKOWSKI, RAYMOND, P</creator><creator>KERKMAN, DANIEL, JOSEPH</creator><scope>EVB</scope></search><sort><creationdate>20001228</creationdate><title>PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME</title><author>DEBERNARDIS, JOHN, FRANCIS ; KOHNKEN, RUSSEL, EDWIN ; ZINKOWSKI, RAYMOND, P ; KERKMAN, DANIEL, JOSEPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0078807A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2000</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DEBERNARDIS, JOHN, FRANCIS</creatorcontrib><creatorcontrib>KOHNKEN, RUSSEL, EDWIN</creatorcontrib><creatorcontrib>ZINKOWSKI, RAYMOND, P</creatorcontrib><creatorcontrib>KERKMAN, DANIEL, JOSEPH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEBERNARDIS, JOHN, FRANCIS</au><au>KOHNKEN, RUSSEL, EDWIN</au><au>ZINKOWSKI, RAYMOND, P</au><au>KERKMAN, DANIEL, JOSEPH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME</title><date>2000-12-28</date><risdate>2000</risdate><abstract>Disclosed are a preparation comprising Alzheimer's disease antigen (A68), methods of obtaining this purified antigen, and methods of using this purified antigen, for instance, for diagnosing Alzheimer's disease and for detecting human autoantibodies to the Alzheimer disease antigen. The antigen preparation according to the invention is purified in that it is substantially free of immunoglobulin G. The invention further relates to methods of making Alzheimer disease antigens that can be used instead of or along with the A68 antigen preparation (e.g., for diagnosing AD), such as recombinant human tau, tau isolated from various species including human, and phosphorylated recombinant human tau or isolated tau, as well as A68 anti-idiotypic antibodies. L'invention concerne une préparation contenant un antigène dirigé contre la maladie d'Alzheimer (A68) et des procédés d'utilisation de cet antigène, par exemple, dans le diagnostic de la maladie d'Alzheimer et la détection des auto-anticorps réagissant à l'antigène dirigé contre la maladie d'Alzheimer. On purifie la préparation de l'invention en la libérant sensiblement d'immunoglobuline G. L'invention concerne aussi des procédés de fabrication d'antigènes, dirigés contre la maladie d'Alzheimer et pouvant être utilisés en guise de substitution ou de complément à l'antigène A68 (p.ex., pour diagnostiquer la maladie d'Alzheimer), tels que du tau humain recombinant, du tau isolé à partir de différentes espèces comprenant les humains et du tau humain recombinant isolé ainsi que des anticorps anti-idiotypitques d'A68.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO0078807A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
SPIRITS
TESTING
VINEGAR
WINE
title PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING AND USING SAME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEBERNARDIS,%20JOHN,%20FRANCIS&rft.date=2000-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0078807A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true